يعرض 2,561 - 2,580 نتائج من 18,221 نتيجة بحث عن 'significantly ((((linear decrease) OR (((we decrease) OR (a decrease))))) OR (greatest decrease))', وقت الاستعلام: 0.67s تنقيح النتائج
  1. 2561

    Image 1_The immunomodulatory and antitumor properties of the bacterial metalloprotease Oligopeptidase A are mediated by TLR4/MyD88/TRIF and MAPK signaling pathways.tif حسب Priscila Silva (556743)

    منشور في 2025
    "…</p>Results<p>Heat-inactivated OpdA significantly reduced metastasis, dependent on tumor-specific CD4+ and CD8+ T cells and IFN-γ, both locally and systemically, with decreased IL-10 levels suggesting a proinflammatory environment. …"
  2. 2562

    Image 3_The immunomodulatory and antitumor properties of the bacterial metalloprotease Oligopeptidase A are mediated by TLR4/MyD88/TRIF and MAPK signaling pathways.tiff حسب Priscila Silva (556743)

    منشور في 2025
    "…</p>Results<p>Heat-inactivated OpdA significantly reduced metastasis, dependent on tumor-specific CD4+ and CD8+ T cells and IFN-γ, both locally and systemically, with decreased IL-10 levels suggesting a proinflammatory environment. …"
  3. 2563

    Exclusion and enrollment summary from NHANES. حسب Lu Han (151620)

    منشور في 2025
    "…Individuals under 30 showed no significant differences. A unit increase below 9.30 in Log2-PMR reduced HCV risk by 0.60-fold. …"
  4. 2564

    The epidemiology and gene mutation characteristics of pyrazinamide-resistant <i>Mycobacterium tuberculosis</i> clinical isolates in Southern China حسب Nan Wang (21935)

    منشور في 2025
    "…This difference in the <i>rpsA</i> mutation rate was statistically significant (<i>P = 0.001</i>, chi-square test). …"
  5. 2565

    Development of Novel PRMT7 Inhibitors for the Treatment of Prostate Cancer حسب Jiaxing Li (113609)

    منشور في 2025
    "…Herein, we reported an effective and selective PRMT7 inhibitor, <b>A33</b>, which was obtained through structural optimization and exhibited potent anti-PCa efficacy in vitro and in vivo. …"
  6. 2566

    Development of Novel PRMT7 Inhibitors for the Treatment of Prostate Cancer حسب Jiaxing Li (113609)

    منشور في 2025
    "…Herein, we reported an effective and selective PRMT7 inhibitor, <b>A33</b>, which was obtained through structural optimization and exhibited potent anti-PCa efficacy in vitro and in vivo. …"
  7. 2567

    Development of Novel PRMT7 Inhibitors for the Treatment of Prostate Cancer حسب Jiaxing Li (113609)

    منشور في 2025
    "…Herein, we reported an effective and selective PRMT7 inhibitor, <b>A33</b>, which was obtained through structural optimization and exhibited potent anti-PCa efficacy in vitro and in vivo. …"
  8. 2568

    Development of Novel PRMT7 Inhibitors for the Treatment of Prostate Cancer حسب Jiaxing Li (113609)

    منشور في 2025
    "…Herein, we reported an effective and selective PRMT7 inhibitor, <b>A33</b>, which was obtained through structural optimization and exhibited potent anti-PCa efficacy in vitro and in vivo. …"
  9. 2569

    The mean and standard deviation of parameters. حسب Sadaf Sepasgozar Sarkhosh (20436143)

    منشور في 2024
    "…Secondary outcomes included performance, fear of movement, and perceived ankle instability, measured using the side-hop test, the Tampa Scale for Kinesiophobia (TSK), and the Cumberland Ankle Instability Tool (CAIT), respectively. Results indicated a significant decrease in ML SI in both groups one month after treatment compared to before and after treatment (P = 0.013 and P<0.001, respectively). …"
  10. 2570

    The ANCOVA and Post_hoc results. حسب Sadaf Sepasgozar Sarkhosh (20436143)

    منشور في 2024
    "…Secondary outcomes included performance, fear of movement, and perceived ankle instability, measured using the side-hop test, the Tampa Scale for Kinesiophobia (TSK), and the Cumberland Ankle Instability Tool (CAIT), respectively. Results indicated a significant decrease in ML SI in both groups one month after treatment compared to before and after treatment (P = 0.013 and P<0.001, respectively). …"
  11. 2571

    CONSORT flowchart. حسب Sadaf Sepasgozar Sarkhosh (20436143)

    منشور في 2024
    "…Secondary outcomes included performance, fear of movement, and perceived ankle instability, measured using the side-hop test, the Tampa Scale for Kinesiophobia (TSK), and the Cumberland Ankle Instability Tool (CAIT), respectively. Results indicated a significant decrease in ML SI in both groups one month after treatment compared to before and after treatment (P = 0.013 and P<0.001, respectively). …"
  12. 2572

    Time to stabilization in the vertical direction. حسب Sadaf Sepasgozar Sarkhosh (20436143)

    منشور في 2024
    "…Secondary outcomes included performance, fear of movement, and perceived ankle instability, measured using the side-hop test, the Tampa Scale for Kinesiophobia (TSK), and the Cumberland Ankle Instability Tool (CAIT), respectively. Results indicated a significant decrease in ML SI in both groups one month after treatment compared to before and after treatment (P = 0.013 and P<0.001, respectively). …"
  13. 2573

    The description of games. حسب Sadaf Sepasgozar Sarkhosh (20436143)

    منشور في 2024
    "…Secondary outcomes included performance, fear of movement, and perceived ankle instability, measured using the side-hop test, the Tampa Scale for Kinesiophobia (TSK), and the Cumberland Ankle Instability Tool (CAIT), respectively. Results indicated a significant decrease in ML SI in both groups one month after treatment compared to before and after treatment (P = 0.013 and P<0.001, respectively). …"
  14. 2574

    The description of balance training. حسب Sadaf Sepasgozar Sarkhosh (20436143)

    منشور في 2024
    "…Secondary outcomes included performance, fear of movement, and perceived ankle instability, measured using the side-hop test, the Tampa Scale for Kinesiophobia (TSK), and the Cumberland Ankle Instability Tool (CAIT), respectively. Results indicated a significant decrease in ML SI in both groups one month after treatment compared to before and after treatment (P = 0.013 and P<0.001, respectively). …"
  15. 2575
  16. 2576
  17. 2577
  18. 2578
  19. 2579
  20. 2580